[go: up one dir, main page]

NL2036639B1 - Preparation method for selenide dihydromyricetin - Google Patents

Preparation method for selenide dihydromyricetin Download PDF

Info

Publication number
NL2036639B1
NL2036639B1 NL2036639A NL2036639A NL2036639B1 NL 2036639 B1 NL2036639 B1 NL 2036639B1 NL 2036639 A NL2036639 A NL 2036639A NL 2036639 A NL2036639 A NL 2036639A NL 2036639 B1 NL2036639 B1 NL 2036639B1
Authority
NL
Netherlands
Prior art keywords
dmy
reaction
selenide
solution
sodium selenite
Prior art date
Application number
NL2036639A
Other languages
Dutch (nl)
Other versions
NL2036639A (en
Inventor
Zhang Chi
Liu Xinping
Tan Mingchun
Shang Longchen
Original Assignee
Zhang Chi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhang Chi filed Critical Zhang Chi
Priority to NL2036639A priority Critical patent/NL2036639B1/en
Publication of NL2036639A publication Critical patent/NL2036639A/en
Application granted granted Critical
Publication of NL2036639B1 publication Critical patent/NL2036639B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C391/00Compounds containing selenium
    • C07C391/02Compounds containing selenium having selenium atoms bound to carbon atoms of six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C391/00Compounds containing selenium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a preparation method for selenide dihydromyricetin (DMY), falling within the technical field of flavonoids development and utilization. DMY and sodium. selenite are included and used as raw materials to optimize the preparation process through single factor experiments and orthogonal experiments, and the structural characterization, stability, antibacterial and antioxidant activities experiments are performed on selenide DMY by atomic fluorescence, ultraviolet, infrared, TG and, XRD. Water‘ is used, as a solvent, effectively avoiding the problems of high cost and environmental pollution in the use of organic solvents, which is environmentally friendly and low—cost, and has great popularization and application value.

Description

P1958 /NLpd
PREPARATION METHOD FOR SELENIDE DIHYDROMYRICETIN
Technical field
The present invention relates to the technical field of fla- vonoids development and utilization, in particularly to a prepara- tion method for selenide dihydromyricetin (DMY).
Background
DMY is mostly extracted from a woody liana belonging to Ampe- lopsis, and is also extracted from Hovenia acerba. The main active component of DMY is a flavonoid compound. Studies have confirmed that DMY has many biological activities such as anti-tumor, anti- bacteria, anti-aging, anti-sensitivity, anti-fatigue, scavenging free radicals, anti-oxidation, anti-thrombosis, anti-tumor, anti- inflammatory and lowering blood glucose. DMY can be made into tab- lets, capsules and other products, and added to animal feed to in- crease meat quality and shorten a growth cycle. DMY is a special flavonoid compound, not only having the general characteristics of the flavonoid compound, but having the functions of relieving al- coholism, preventing alcoholic hepatitis and fatty liver, inhibit- ing the deterioration of liver cells and reducing the incidence of liver cancer, which is a good product for protecting liver and re- lieving hangover.
At present, selenium can't be synthesized in human body, which can only be supplemented by exogenous selenium. Organic selenides in selenium supplements can effectively avoid poisoning caused by inorganic selenium, and there are some problems related to poor water solubility (the solubility being only 263.54 mg/L at 25°C), poor stability, poor antioxidant activity, low intestinal mucosal permeability, short half-life in vivo, low pharmacological activity and easy discoloration. These problems have become the main bottleneck factors limiting the wide application of selenium, and the use of organic solvents is high-cost and pollutes the en- vironment.
Summary
Technical problem solved
Aiming at the shortcomings of the prior art, the present in- vention provides a preparation method for selenide DMY, which solves the problems of poor water sclubility, poor stability, poor antioxidant activity, low intestinal mucosal permeability, short half-life in vivo, low pharmacological activity, easy discolora- tion and high cost and environmental pollution caused by the use of organic solvents.
Technical solution
In order to achieve the above objectives, the present inven- tion is realized by the following technical solutions. A prepara- tion method for selenide DMY includes DMY and sodium selenite. DMY and sodium selenite are used as raw materials to optimize the preparation process through single factor experiments and orthogo- nal experiments, and the structural characterization, stability, antibacterial and antioxidant activities experiments are performed on selenide DMY by atomic fluorescence, ultraviolet, infrared, TG and XRD.
Preferably, the material ratio in the S3 may also be 1:0.25, 1:0.5, 1:1 or 1:2, the reaction time may also be 40, 60, 80 or 100 min, and the reaction temperature may also be 15, 35, 55 or 75°C; and in the reaction step of the S4, HCl is utilized to adjust the pH to 8, 7 or 2.
Preferably, a reaction condition of the S3 is that the reac- tion is carried out in an inert atmosphere (such as a nitrogen at- mosphere) to prevent oxygen from interfering with the reaction.
Preferably, a preparation method for selenide DMY includes the following steps:
Sl: material preparation preparing enough DMY and sodium selenite in proportion;
S2: solution selection selecting a saturated Na,CO; solution to cause reactants to be fully dissolved and reacted;
S3: reaction conditions setting a material ratio of DMY to sodium selenite as 1:3,
with a reaction time of 120 min and a reaction temperature of 95°C; and
S4: reaction steps a: dissolving a portion of DMY in the saturated Na;CO; solu- tion to obtain a DMY solution, b: gradually adding three portions of sodium selenite into the DMY solution and stirring a reaction mixture, c: reacting the mixture for 120 min at a reaction temperature of 95°C, and heating and refluxing the same, and d: adjusting a pH with HCl after the reacting, centrifuging the mixture, sequentially eluting the same with boiling distilled water and iced distilled water, and performing vacuum drying on the same to obtain powdery solid.
Advantageous effects
The present invention provides a preparation method for sele- nide DMY. The present invention has the following advantageous ef- fects. 1. According to the present invention, the preparation of selenide DMY by using water as the solvent has the advantages of environmental protection and low cost, and the stability and bio- logical activity of selenide DMY obtained by structural modifica- tion of DMY with selenium are improved. The preparation technology and related parameters of selenide DMY have a simple technological process, safe operations and low cost in production, which is suitable for batch processing, and can be widely used in experi- ments or industrial production. Water, selected as the solvent, effectively avoiding the problems of high cost and environmental pollution caused by the use of organic solvents, is environmental- ly friendly and low-cost, and has great popularization and appli- cation value. 2. According to the present invention, the active substance
DMY extracted and purified from natural product Vine tea is used as a substrate, and Na,CO; is used as a selenizing agent, and the structure of DMY is modified by selenization to prepare the organ- ic selenide DMY. The thermal stability of the obtained selenide
DMY in a range of 250°C-370°C is better than that of DMY, and the stability in an aqueous solution is good, and the antioxidant ac-
tivity is better than that of DMY, which is positively related to a sample amount. Therefore, the organic selenide DMY has good thermal stability, aqueous solution stability, antibacterial ac- tivity and strong antioxidant activity.
Brief description of the drawings
FIG. 1 is an ultraviolet spectrogram of the influence of a heating temperature on the stability of selenide DMY according to the present invention;
FIG. 2 is an ultraviolet spectrogram of the influence of a pH on the stability of selenide DMY according to the present inven- tion;
FIG. 3 is an ultraviolet spectrogram of the influence of a heating time on the stability of selenide DMY according to the present invention; and
FIG. 4 is a graph showing scavenging rates of DMY and sele- nide DMY to «OH radicals according to the present invention.
Detailed description
Technical solutions in the examples of the present invention will be described clearly and completely in the following with reference to the attached drawings in the examples of the present invention. Obviously, all the described examples are only some, rather than all examples of the present invention. Based on the examples in the present invention, all other examples obtained by those of ordinary skill in the art without creative efforts belong to the scope of protection of the present invention.
Example 1
As shown in FIGS. 1-4, an example of the present invention provides a preparation method for selenide DMY, including DMY and sodium selenite. DMY and sodium selenite are used as raw materials to optimize the preparation process through single factor experi- ments and orthogonal experiments, and the structural characteriza- tion, stability, antibacterial and antioxidant activities experi- ments are performed on selenide DMY by atomic fluorescence, ultra- violet, infrared, TG and XRD.
The material ratio in the 33 may also be 1:0.25, 1:0.5, 1:1 or 1:2, the reaction time may also be 40, 60, 80 or 100 min, and the reaction temperature may also be 15, 35, 55 or 75°C.
In the reaction step of the S4, HCl is utilized to adjust the
PH to 8, 7 or 2.
A reaction condition of the S3 is that the reaction is car- ried out in an inert atmosphere (such as a nitrogen atmosphere) to 5 prevent oxygen from interfering with the reaction.
Example 2
As shown in FIGS. 1-4, an example of the present invention provides a preparation method for selenide DMY, including the fol- lowing steps.
At S1: material preparation enough DMY and sodium selenite were prepared in proportion.
At S2: solution selection a saturated Na:CO: solution was selected to cause reactants to be fully dissolved and reacted.
At S3: reaction conditions a material ratio of DMY was set to sodium selenite as 1:3, with a reaction time of 120 min and a reaction temperature of 95°C.
At S4: reaction steps a: a portion of DMY was dissolved in the saturated Na,CO; so- lution to obtain a DMY solution, b: three portions of sodium selenite were gradually added in- to the DMY solution and a reaction mixture was stirred, c: the mixture was reacted for 120 min at a reaction tempera- ture of 95°C, heated and refluxed, and d: a pH was adjusted with HCl after the reacting, centri- fuged, sequentially eluted with boiling distilled water and iced distilled water, and vacuum dried to obtain powdery solid.
Example 3
As shown in FIGS. 1-4, an example of the present invention provides a preparation method, experiments and optimization for selenide DMY, including the following steps. (1) Single factor experiments: DMY and sodium selenite were weighed in proportion, an appropriate amount of distilled water was taken as a solvent, a pH of a reaction system was adjusted with a saturated Na:CO: solution, the reaction system was heated and refluxed, the pH was adjusted with HCl after the reaction, and the mixture was centrifuged, sequentially eluted with boiling dis-
tilled water and iced distilled water, and vacuum dried to obtain yellow-brown powdery solid. The single factor experiments were performed with material ratios of 1:0.25, 1:0.5, 1:1, 1:2 and 1:3 for reaction times of 40, 60, 80, 100 and 120 min at reaction tem- peratures of 15, 35, 55, 75 and 95°C, and pHs of the reaction sys- tem were 8, 7 and 2. When the material ratios were 1:0.25, 1:0.5, 1:1, 1:2 and 1:3, selenium source utilization ratios of selenide
DMY were 0.08%, 0.21%, 0.23%, 1.12% and 1.50%; when the reaction times were 40, 60, 80, 100 and 120 min, selenium source utiliza- tion rates of selenide DMY were 2.73%, 0.89%, 0.54%, 0.17% and 1.58%; and when the reaction temperatures were 15, 35, 55, 75 and 95°C, selenium source utilization rates of selenide DMY were 0.003%, 0.006%, 0.51%, 27.44% and 29.38%; when the pHs of the re- action system were 8, 7 and 2, selenium source utilization rates of selenide DMY were 0.54%, 1.43% and 0.07%; and finally, the se- lenium source utilization rate of selenide DMY was 29.38% when the ratio was 1:3, the reaction time was 120 min and the reaction tem- perature was 95°C. {2) Orthogonal experiments: according to the results of the single factor experiments, the material ratios were 1:0.25, 1:0.5, 1:1 and 1:2, the reaction times were 60, 80, 100 and 120 min, the reaction temperatures were 35, 55, 75 and 95°C, and four-factor and four-level orthogonal experiments were designed for the reaction system at pHs of 2, 7, 8 and 9. The utilization rates of selenium source were taken as performance indexes, the optimized process parameters for preparing selenide DMY were determined by SPSS23.0 analysis. The test results were shown in Table 1. (3) An optimized process for preparing selenide DMY: DMY and sodium selenite were weighted according to a material ratio of 1:0.25, an appropriate amount of distilled water was taken as a solvent, a pH of a reaction system was adjusted to 8, the reaction system was heated and refluxed at 95°C for 120 min, the pH was ad- justed with HCl after the reaction, and the mixture was centri- fuged, sequentially eluted with boiling distilled water and iced distilled water, and vacuum dried to obtain yellow-brown powdery solid. Under the optimized process conditions, a selenium source utilization rate of the prepared selenide DMY was 80.73%. A ultra- violet spectrum showed that there were structural characteristic peaks of flavonoids (208.5 nm) and flavonols (358.5 nm) in sele- nide DMY. An infrared spectrum showed that a benzene ring struc- ture still existed in selenide DMY, and C=0, -OH and Se* of DMY were selenized to form new rings, and a new characteristic absorp- tion peak of Se-0O appeared. TG showed that the thermal stability of selenide DMY was higher than that of DMY in a range of 250°C- 370°C, and XRD showed that crystal diffraction peaks of selenide
DMY were 8.96°, 11.92°, 14.58°, 23.46°, 26.88°, 29.62°, 36.14°, 43.54° and 45.26°. Selenide DMY is formed by chemical reactions, not simple physical mixing. (4) Stability experiments: 15 mL of sample solution was taken in a small test tube, heating temperatures, pHs and heating times were changed sequentially, and an ultraviolet spectrum was meas- ured in a range of 250-500 nm, where the heating temperatures were 10, 35, 55, 75, 95 and 100°C, pH values were 2, 4, 6, 7, 8, 10 and 12, and the heating timed were 10, 20, 30, 40, 50 and 60 min. The results of stability experiments were shown in FIGS. 1-3. From
FIG. 1, it could be seen that when the temperature was 10°C-100°C, positions of characteristic absorption peaks of selenide DMY did not change obviously, indicating that selenide DMY existed stably without obvious decomposition. From FIG. 2, it could be seen that characteristic absorption peaks of a selenide DMY aqueous solution with a PH value of 6 were consistent with that with a pH adjusted to be acidic, but different from that with pHs adjusted to be neu- tral, weakly alkaline and alkaline, indicating that selenide DMY was stable under acidic conditions and unstable under neutral and slightly alkaline conditions. From FIG. 3, it could be seen that positions of the characteristic absorption peaks of selenide DMY were basically consistent when the heating time was 10 min-60 min, indicating that it existed stably without decomposition. The sta- bility experiments showed that the selenide DMY aqueous solution had good stability. (5) Antioxidant activity experiments: 2 mL of sample solu- tions with different concentration gradients, 2 mL of 6 mmol/L
FesS0, solution, 2 mL of 6 mmol/L salicylic acid-ethanol solution and 2 ml of 6 mmol/L LH:0: solution were added to an appropriate amount of small test tubes, then an absorbance value was measured at 510 nm after holding in water bath at 37°C for 30 min, and an «OH radical scavenging rate (%) was calculated. The experimental results were shown in FIG. 4. In experimental ranges, when the sample concentration was 300 pg/mL, the scavenging rates of ¢CH radicals of DMY and selenide DMY were the highest, which were 31.40% and 56.40% respectively. The scavenging rate of selenide
DMY on sOH radicals was better than that of DMY, and the antioxi- dant experiments showed that selenide DMY had good antioxidant ac- tivity.
Table 1 Orthogonal experiment results
Serial A material B reaction Dreac temperature number ratio time (min) (°C) tion pH 1 2 3 1 1{1:0.25) 1{60) 1{35) 1{2} 12.63% 12.33% 12.55% 2 1 2{80) 2(55) 2(7) 0.54% 0.49% 0.51% 3 1 3{100} 3{75) 3{8) 50.59% 52.38% 50.89% 4 1 4{120) 4(95) 4(9) 71.88% 73.64% 72.76% 5 2{1:0.5) 1 2 3 0.19% 0.17% 0.15% 6 2 2 1 4 1.42% 2.08% 2.29% 7 2 3 4 1 3.23% 3.20% 3.22% 8 2 4 3 2 54.12% 54.42% 52.20% 9 3(1:1) 1 3 4 20.32% 20.44% 20.48% 10 3 2 4 3 21.02% 20.73% 20.87% 11 3 3 1 2 0.07% 0.07% 0.08% 12 3 4 2 1 1.13% 1.10% 0.72% 13 4(1:2) 1 4 2 7.31% 7.45% 7.39% 14 4 2 3 1 0.31% 0.29% 0.24% 4 3 2 4 1.75% 1.72% 1.73% 16 4 4 1 3 0.28% 0.29% 0.30% "While examples of the present invention have been shown and _ 15 described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations may be made herein without departing from the principles and spirit of the present invention, the scope of which is defined by the ap- pended claims and equivalents thereof.

Claims (4)

CONCLUSIESCONCLUSIONS 1. Werkwijze voor het bereiden van selenidedihydromyricetine (DMY), omvattende DMY en natriumseleniet, waarbij DMY en natrium- seleniet als grondstoffen worden gebruikt om het de bereidings- werkwijze te optimaliseren door middel van single-factor experi- menten en orthogonale experimenten, en waarbij de structurele ka- rakterisering, stabiliteit, antibacteriële en antioxidant activi- teitsexperimenten worden uitgevoerd op selenide DMY door middel van atomaire fluorescentie, ultraviolet, infrarood, TG en XRD.1. A method for preparing selenide dihydromyricetin (DMY) comprising DMY and sodium selenite, wherein DMY and sodium selenite are used as raw materials to optimize the preparation process by single-factor experiments and orthogonal experiments, and wherein the structural characterization, stability, antibacterial and antioxidant activity experiments are carried out on selenide DMY by atomic fluorescence, ultraviolet, infrared, TG and XRD. 2. Werkwijze voor het bereiden van selenide DMY volgens conclusie 1, omvattende de volgende stappen: Sl: voorbereiding van het materiaal voorbereiding van voldoende DMY en natriumseleniet in verhouding; S2: oplossing selectie kiezen van een verzadigde Na:CO;:-oplossing om de reactanten volle- dig op te lossen en te laten reageren; S3: reactieomstandigheden een materiaalverhouding van DMY tot natriumseleniet instellen van 1:3, met een reactietijd van 120 min en een reactietemperatuur van 95 °C; en S4: reactiestappen a: oplossen van een deel DMY in de verzadigde Na:CO:-oplossing om een DMY-oplossing te verkrijgen, b: geleidelijk toevoegen van drie delen natriumseleniet aan de DMY-oplossing en roeren van een reactiemengsel, c: reactie van het mengsel gedurende 120 minuten bij een reac- tietemperatuur van 95 °C, en verwarmen en refluxen daarvan, en d: aanpassen van de pH met HCl na de reactie, centrifugeren van het mengsel, achtereenvolgens elueren met kokend gedestil- leerd water en ijskoud gedestilleerd water, en vacuümdrogen van het mengsel om een poedervormige vaste stof te verkrijgen.2. A method for preparing selenide DMY according to claim 1, comprising the steps of: S1: preparing material preparing sufficient DMY and sodium selenite in proportion; S2: solution selection choosing a saturated Na:CO; solution to completely dissolve and react the reactants; S3: reaction conditions setting a material ratio of DMY to sodium selenite of 1:3, with a reaction time of 120 min and a reaction temperature of 95°C; and S4: reaction steps a: dissolving one part of DMY in the saturated Na:CO: solution to obtain a DMY solution, b: gradually adding three parts of sodium selenite to the DMY solution and stirring a reaction mixture, c: reacting the mixture for 120 minutes at a reaction temperature of 95 °C, and heating and refluxing it, and d: adjusting the pH with HCl after the reaction, centrifuging the mixture, eluting with boiling distilled water and ice-cold distilled water successively, and vacuum-drying the mixture to obtain a powdery solid. 3. Werkwijze voor het bereiden van selenide DMY volgens conclusie 1, waarin de materiaalverhouding in de stap S3 ook 1:0.25, 1:0.5,3. A method for preparing selenide DMY according to claim 1, wherein the material ratio in step S3 is also 1:0.25, 1:0.5, 1:1 of 1:2 kan zijn, de reactietijd ook 40, 60, 80 of 100 minuten kan zijn en de reactietemperatuur ook 15, 35, 55 of 75 °C kan zijn; en in de reactiestap van S4 wordt HCl gebruikt om de pH aan te passen tot 8, 7 of 2.can be 1:1 or 1:2, the reaction time can also be 40, 60, 80 or 100 minutes, and the reaction temperature can also be 15, 35, 55 or 75 °C; and in the reaction step of S4, HCl is used to adjust the pH to 8, 7 or 2. 4. Werkwijze voor het bereiden van selenide DMY volgens conclusie 1, waarin een reactievoorwaarde van stap S3 is dat de reactie wordt uitgevoerd in een inerte atmosfeer, bijvoorbeeld een stik- stofatmosfeer, om te voorkomen dat zuurstof de reactie verstoort.4. The process for preparing selenide DMY according to claim 1, wherein a reaction condition of step S3 is that the reaction is carried out in an inert atmosphere, for example, a nitrogen atmosphere, to prevent oxygen from interfering with the reaction.
NL2036639A 2023-12-22 2023-12-22 Preparation method for selenide dihydromyricetin NL2036639B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL2036639A NL2036639B1 (en) 2023-12-22 2023-12-22 Preparation method for selenide dihydromyricetin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL2036639A NL2036639B1 (en) 2023-12-22 2023-12-22 Preparation method for selenide dihydromyricetin

Publications (2)

Publication Number Publication Date
NL2036639A NL2036639A (en) 2024-01-26
NL2036639B1 true NL2036639B1 (en) 2024-08-13

Family

ID=89621215

Family Applications (1)

Application Number Title Priority Date Filing Date
NL2036639A NL2036639B1 (en) 2023-12-22 2023-12-22 Preparation method for selenide dihydromyricetin

Country Status (1)

Country Link
NL (1) NL2036639B1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2005955A4 (en) * 2006-03-31 2009-10-28 Fulin Fan FORMULATIONS OF AN UNSATURATED SALT OF AMPELOPSIN AND ITS APPLICATION
CN108409621A (en) * 2017-02-10 2018-08-17 上海爱启生态科技有限公司 A kind of dihydromyricetin selenium compound for treating liver cancer and related liver disease
CN111454240B (en) * 2020-04-30 2023-05-16 上海爱启医药技术有限公司 Process for preparing diselenide compounds
CN111393408A (en) * 2020-04-30 2020-07-10 上海爱启医药技术有限公司 Method for preparing natural flavone selenium
CN112570726B (en) * 2020-11-24 2023-07-28 山东省分析测试中心 Dihydromyricetin functionalized silver nanoparticles and its green synthesis method and application
CN112451514A (en) * 2020-11-26 2021-03-09 江西农业大学 Dihydromyricetin nano-selenium and preparation method and application thereof

Also Published As

Publication number Publication date
NL2036639A (en) 2024-01-26

Similar Documents

Publication Publication Date Title
NL2036639B1 (en) Preparation method for selenide dihydromyricetin
CZ279815B6 (en) Process for preparing d,1-5-methyltetrahydrofolic acid or salts thereof being acceptable from pharmaceutical point of view
Bolognesi et al. The crystal and molecular structure of two models of catalytic flavo (co) enzyme intermediates
WO2021217825A1 (en) Method for preparing diselenide compound
Forrest et al. Isolation and characterization of a yellow pteridine from the blue-green alga, Anacystis nidulans
CN105713104B (en) A kind of synthesis and its application of selenizing Fenugreek Polysaccharides
Szczerba et al. Mechanochemical synthesis of bismuth active pharmaceutical ingredients, bismuth (III) gallate and bismuth citrate
CN111848593B (en) Water-soluble isoorientin-zinc complex and preparation method and application thereof
CN109096053B (en) Synthesis method of OLED intermediate and semiconductor material 1-hydroxypyrene
Erzunov et al. Investigation of catalytic processes of thio-compounds conversion to disulfides using novel butyl/butoxy-phthalocyaninates of d-metals
CN118994129B (en) Vitamin C derivative and preparation method and application thereof
CN109912608A (en) Hydroxyl replaces click to cough up complex and preparation method thereof
Lambein et al. Isolation and characterization of 2-(β, D-glucopyranosyl)-4alanyl-3-Isoxazolin-5-one: A second UV-sensitive heterocyclic α-amino acid from Pisum sativum L.
CN108473509A (en) The preparation method of C-Met tyrosine kinase inhibitors
Nijenhuis et al. PHOTOCHEMICAL AROMATIC HYDROXYLATION OF FLAVINS UNDER ANAEROBIC CONDIIONS
CN109929106B (en) A kind of fluorescent probe for detecting thiocyanate and its preparation method and application
Silber et al. Photoreactions of riboflavin in the presence of 2, 4-dichlorophenoxyacetic acid (2, 4-D)
CN113896665A (en) Preparation method of 2-chloro-1-methyl-4- (methylsulfonyl) benzene
Alejo-Armijo et al. Generalization of the anthocyanins kinetics and thermodynamics multistate to 2, 6-bis (2-hydroxybenzylidene) cyclohexanones
YAMAJI et al. The Synthesis of 2-Substituted 1, N6-Etheno-adenosine-3', 5'-cyclic Phosphate by Ring Reclosure of Alkali-hydrolizate of 1, N6-Etheno-adenosine-3', 5'-cyclic Phosphate
Henry Crystalline Complexes of 1, 3, 5-Trinitrobenzene and Alkali Sulfites
Elizbarashvili et al. Synthesis of macrocyclic polyazomethines
CN119841879B (en) Supermolecule arbutin nicotinamide, preparation method thereof and daily chemical product
Vlasenko et al. α-Amino acid-assisted autoxidation of naphthalene proton sponge affording 1, 4-naphthoquinone nitrogen derivatives
Gavalás-Olea et al. Enzymatic synthesis and characterization of chlorophyllide derivatives as possible internal standards for pigment chromatographic analysis